ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14225QMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 4 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14226RMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 4 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14247WMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 5 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14248XMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 3 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14249YMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 7 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14250BMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 5 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14255GMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 7 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14266WMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 5 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14267XMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 7 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14268YMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 7 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14269BMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 7 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14277KMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 3 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14278LMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 3 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14288BMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 7 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14289CMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 3 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14298MMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 5 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | General Schedule | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14566PMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 8 | $6910.30 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
ATEZOLIZUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 14575DMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 8 | $6747.37 | $31.60 | $31.60 | 
| Available brands | |||||||
| Tecentriq SC | 
- Legend
 - MPMedical Practitioner
 




